Member Info for squadraazzura

There are many similar companies but they need to be approved first. Some are OK some are really charlatans just wanting to make quick money then disappear.

Is a non-stop decline of share price since January normal ? I cannot find anything logical in the process. Even horrible stocks with huge losses and horrible results have recovered. IMO this is artificially engineered via a "common agreement".

hTtps://twitter.com/two_fresh/status/1357737199714922497

Worries about new variants: - - - hTtps://www.bbc.co.uk/news/uk-55976037

In order avoid the risk of missing the South African, the Brazilian and the UK variants, they must use NCYT new tests all the time. The demand for NCYT test will be huge as the new variants are spreading in the US too - according to Doctor Campbell.

When NCYT portfolio is complete in Q1 - 2021, by launching POC rapid tests including antibodies, NCYT would become one of the major companies offering all tests from one single source, including identification of new variants.

Vaccine only 10% effective against latest virus.
https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-covid-uk-vaccine-passport-targets-lockdown/

Sanofi will be the best fit for diagnostics. One of the biggest vaccine pharma in the world.

To be convinced that the NCYT share price is manipulated is when one looks at those Covid companies with tests not even approved to see them going up 15%. Here we are dealing with a company selling millions of approved tests all over the world, sitting on 100 million cash with rapid tests for both, antigen and antibodies to be released in Q1 2021. Very strange indeed. I think the recovery will be very sharp when it happens.
The only worry for humanity is that the big pharmas will need to restart all over again with the vaccine concept due to the new variants. So the questions to ask now are: 1/ For how long the existing vaccines will protect ? 2/ For which variants are they effective ?
hTtps://www.itv.com/news/2021-02-07/study-shows-oxfordastrazeneca-jab-less-effective-against-south-african-variant

NCYT is going to launch its rapid tests for both antigen and antibody tests in Q1 2021 as per their update to cover all the viral testing range. Then for how long the present vaccines will protect ? The latest news on all channels are now telling us the vaccines are not effective against the South African variant. A new vaccine is anticipated before winter 2021. So my conclusion is that testing will never go away and with a cash pile to exceed £500 millions in the next 2 years, NCYT will definitely be taken over. So savvy investors are positioned to be in a win win situation. IMO buy/ top up and hold. This is the only diagnostics biotech making loads of money.

The turn for gold recovery is expected very soon. All economic indicators are in the red with redundancies at all time high. It's just a matter of being patient.

The last Trading Update + restructuring was not bad at all."Power Systems end markets seeing some early signs of improvement -- Defence remains resilient with strong order cover for 2021 -- Civil Aerospace large engine flying hours gradually recovering; year-to-date 42% of 2019" - IMO this is a very good level to start accumulating.

The share price is now at all time low, considering the worst case scenario. I cannot believe this reflects its true value so I just bought a good chunk at these very cheap levels. Noting that PFC is now fully involved in green/renewable energies: - - - hTtps://renewablesnow.com/news/petrofac-wins-engineering-deal-for-aussie-green-hydrogen-project-715995/

Strange that almost all gold miners, from PLY to FRES and HOC rose today except AAZ.

Interesting play in the mobile gaming sector. The last Trading Update shows this could become big and I have just made my first purchase today to keep for a while. When one looks what the likes of CDM, TM17 and GAW have reached today , I won't be surprised to see GMR do the same in a year of two.

Any news on the special divi this January mentioned in the past ?

I have topped up a few times since the start of the drop. Approval is not limited to FDA only as many other countries in Europe and Asia (China/Japan etc.) may announce its adoption as phase 3 was already a success. POLX is a solid long term hold.

The company doesn't hold 100% to the FDA decision. I think there will be plenty of positive news that will propel the SP in the coming weeks and months.

I have topped up a few times throughout this week. I think 5G will positively affect all companies involved in it. CLX being one of the main providers of test equipment where barriers of entry are high.

Not a good signal for the confidence in the company when a CFO offloads shares ! "Tracsis is a leading provider of software, hardware and services for the rail, traffic data and wider transport industries, and confirms that on 14 December 2020, its Chief Financial Officer Max Cawthra sold 75,000 ordinary shares in Tracsis at a price of 638.7p."